Опухоли головы и шеи. 2014; : 55-56
BAYER HEALTHCARE
https://doi.org/10.17650/2222-1468-2014-0-1-55-56Аннотация
Список литературы
1. Инструкция по применению лекарственного препарата для медицинского применения НЕКСАВАР № ЛСР-000093 от 19.03.2014.
2. Brose M.S. Sorafenib in locally advanced or metastatic patients with radioactive iodinerefractory differentiated thyroid cancer: The phase III DECISION trial. Oral presentation on 2013 ASCO Annual Meeting.
3. Brose M.S., Nutting C., Jarzab B. et al. Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial. J Clin Oncol 2013;31(suppl):abstr 4.
Head and Neck Tumors (HNT). 2014; : 55-56
BAYER HEALTHCARE
https://doi.org/10.17650/2222-1468-2014-0-1-55-56Abstract
References
1. Instruktsiya po primeneniyu lekarstvennogo preparata dlya meditsinskogo primeneniya NEKSAVAR № LSR-000093 ot 19.03.2014.
2. Brose M.S. Sorafenib in locally advanced or metastatic patients with radioactive iodinerefractory differentiated thyroid cancer: The phase III DECISION trial. Oral presentation on 2013 ASCO Annual Meeting.
3. Brose M.S., Nutting C., Jarzab B. et al. Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial. J Clin Oncol 2013;31(suppl):abstr 4.
